Business Context and Reporting Period
Company: Kimberly-Clark Corporation (KMB)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: A global manufacturer of essential consumer and professional products (Baby & Child Care, Adult Care, Feminine Care, Family Care, Professional) operating in over 175 countries. Key brands include Huggies, Kleenex, Scott, Kotex, and Depend.
Strategic Restructuring: The company reorganized its continuing operations into two reportable segments: North America (NA) and International Personal Care (IPC). The former International Family Care and Professional (IFP) segment is now reported as discontinued operations pending a joint venture transaction with Suzano S.A. expected to close in mid-2026.
Key Financial Metrics (2025 vs. 2024)
| Metric (in millions, except per share) | 2025 | 2024 | % Change |
|---|---|---|---|
| Net Sales | $16,447 | $16,805 | (2.1)% |
| Gross Profit | $5,923 | $6,289 | (5.8)% |
| Gross Margin | 36.0% | 37.4% | (140 bps) |
| Operating Profit | $2,351 | $2,700 | (12.9)% |
| Income from Continuing Operations | $1,649 | $2,192 | (24.8)% |
| Net Income (Attributable to K-C) | $2,021 | $2,545 | (20.6)% |
| Diluted EPS (Continuing Ops) | $4.86 | $6.41 | (24.2)% |
| Cash Provided by Operations | $2,777 | $3,234 | (14.1)% |
| Total Debt (Continuing Ops) | $7,200 | $7,400 | (2.7)% |
| Cash and Cash Equivalents | $688 | $1,010 | (32.0)% |
Note: Net Income includes $400 million from discontinued operations (IFP Business).
Material Changes and Drivers
- Revenue Decline: Net sales decreased 2.1% primarily due to divestitures and business exits (2.9% impact) and unfavorable currency translation (0.9% impact). These were partially offset by organic sales growth of 1.7%, driven by volume gains of 2.5%.
- Profitability Pressure: Operating profit declined 12.9%. This was driven by a $565 million gain from the sale of the PPE business in 2024 that did not recur, alongside $348 million in charges related to the 2024 Transformation Initiative and $32 million in Kenvue acquisition costs in 2025.
- Adjusted Performance: On an adjusted basis (excluding transformation charges, acquisition costs, and one-time items), Adjusted Operating Profit was flat at $2.7 billion, and Adjusted EPS was $6.12, down slightly from $6.16 in 2024.
- Tax Rate Increase: The effective tax rate rose to 29.2% from 18.3% in the prior year, largely due to a valuation allowance on U.S. foreign tax credits resulting from the "One Big Beautiful Bill Act" (OBBBA).
- Segment Performance:
- North America: Sales down 2.4%; Operating profit flat (+0.4%).
- International Personal Care: Sales down 0.9%; Operating profit down 3.6% due to currency impacts and pricing pressures.
Guidance, Outlook, and Risks
Pending Transactions
- Kenvue Acquisition: On November 2, 2025, K-C agreed to acquire Kenvue, Inc. for approximately $6.7 billion in cash and stock. The deal is expected to close in the second half of 2026, subject to regulatory approvals. This will significantly increase the company's debt load.
- IFP Transaction: A joint venture with Suzano S.A. for the IFP Business is expected to close in mid-2026 for approximately $1.7 billion (51% stake to Suzano). Proceeds will help fund the Kenvue acquisition.
Transformation Initiative
The 2024 Transformation Initiative aims to reduce structural costs by $3.0 billion in gross productivity and $200 million in SG&A by the end of 2026. Total expected costs are $1.5 billion pre-tax. Cumulative charges through 2025 were $808 million.
Key Risks
- Input Costs: Volatility in pulp, resin, and energy prices, plus approximately $100 million in incremental tariff-related costs in 2025.
- Geopolitical: Ongoing war in Ukraine impacts operations in Russia (approx. 1-2% of global sales) and creates supply chain/currency risks.
- Integration: Risks associated with integrating Kenvue and the potential failure to realize anticipated synergies.
- Regulatory: Changes in tax laws (OBBBA) and global data privacy regulations.
Investor Verification Checklist
- Kenvue Deal Status: Monitor regulatory approval progress and potential termination fees ($1.1 billion) if the merger fails.
- Debt Capacity: Verify the company's ability to service increased debt levels post-Kenvue acquisition, given the current $7.2 billion debt load.
- Transformation Execution: Track progress on the $1.5 billion cost reduction plan and the associated workforce reductions (4-5% of workforce).
- Organic Growth: Assess sustainability of 1.7% organic sales growth amidst declining birth rates in key markets (China, US, South Korea).
- Tax Implications: Review the long-term impact of the OBBBA on the effective tax rate and foreign tax credit utilization.
- IFP Closing: Confirm the mid-2026 closing of the Suzano joint venture to ensure expected cash proceeds materialize.